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Abstract 
 
Alcoholic liver disease is a term that encompasses the hepatic manifestations 
of alcohol overconsumption, including fatty liver, alcoholic hepatitis, and 
chronic hepatitis with hepatic fibrosis or cirrhosis. Alcoholic liver disease (ALD) is the most 
prevalent cause of advanced liver disease. However, there has been limited research 
investment into ALD despite its significant burden on the health. Many patients of ALD 
having the clinical manifestations viz.ascites, hepatitis etc. used to visit the OPD of Dr. M.N. 
Agashe hospital, Satara.Hence, being an Ayurvedic hospital it was decided to work upon 
ALD with some Ayurvedic medicines. For that total 30 patients of ALD were selected and 
treated with ‘AmalakyadiKwatha’ (containing Amalaki, Haritaki and Guduchi and Katuki in 
equal proportion). The formulation was given in the dose of 20 ml twice a day for the 
duration of one month. All the necessary parameters along with required investigations were 
assessed. In the results, weight of the patients was reduced by 12.13%. The parameters like 
abdominal girth (7.13 %↓), distance between umbilicus and xiphisternum (17.34 %↓), 
distance between umbilicus and pubis (19.18 %↓), distance between umbilicus and right 
anterior superior iliac crest (19.55 %↓), distance between umbilicus and left anterior superior 
iliac crest (16.83 %↓) showed highly significant results. The biochemical parameters such as 
Bilirubin, SGPT and SGOT also showed significant reduction in their levels. Hence, it can be 
said that Aamlakyadi kwath can be a good option for disease like ALD instead of repeated 
abdominal paracentesis. 
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Introduction: 
Alcoholic liver disease (ALD) is the most 
prevalent cause of advanced liver disease. 
However, there has been limited research 
investment into ALD despite its significant 
burden on the health. ALD is a complex 
disease, the successful management of 
which hinges on the integration of all the 
competences in public health, 
epidemiology, addiction behavior and 
alcohol-induced organ injury. Both 
primary intervention to reduce alcohol 
abuse and secondary intervention to 
prevent alcohol-associated morbidity and 
mortality rely on the coordinated action of 
multidisciplinary teams established at 
local, national, and international levels. 
ALD is not directly mentioned in 
Ayurveda but the disease can be compared 
with Sannipataj Udara. The symptoms of 
the disease are swelling of the abdomen, 
hands, legs, discoloration of nails, eyes, 
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face, skin, urine and stool, appearance of 
networks of veins on abdomen etc.(1) 
which are very much similar to alcoholic 
liver disease. Another fact is that the cause 
mentioned for Sannipataj Udara is 
‘Manda Visha’ (slow poison) which can be 
considered as alcohol.(2) Hence by seeing 
the causes as well as the symptoms the 
disease ALD could be taken as ‘Sannipataj 
Udara’ according to Ayurveda. 
Many patients of ALD having the clinical 
manifestations viz.ascites, hepatitis etc. 
used to visit the OPD of Dr. M.N. Agashe 
hospital, Satara.Hence, being an 
Ayurvedic hospital it was decided to work 
upon ALD with some Ayurvedic 
medicines. For this, four drugs viz. 
Amalaki, haritaki, Guduchi and Kutaki 
were selected and the formulation was 
named as Amalakyadi Kwatha. The 
rationale of selection of these drugs is 
mentioned later in this article. Hence with 
the aim to evaluate the efficacy of 
Amalakyadi Kwath on alcoholic liver 
disease the present study has been taken 
under. 
Materials and methodology: 
Total 30 patients suffering from alcoholic 
liver disease between the age group of 25 
– 60 years were selected from the OPD 
and IPD of Dr. M. N. Agashe hospital, 
Satara irrespective of their sex and 
religion. 
 
Inclusion Criteria: 
1. Patients of Liver parenchymal 
disease including fatty changes and 
cirrhosis with ascites without any 
bar of caste, sex and religion. 
2. Patients having excessive alcohol 
consumption 
3. Patients having age between 25 to 
60 yrs. 
 
Exclusion Criteria: 
1. Patients having age less than 25yrs 
and more than 60yrs 
2. Patients having severe cardiac, 
renal disease, altered 
consciousness, malignancy, AIDS, 
neurological disorders etc. 
3. Pregnant and lactating women 
4. Non-alcoholic liver disease 
 
Drug: 
All the patients were provided with 
‘Amalakyadi Kwatha’. The ingredients of 
the formulation and their quantity is 
mentioned in the below table 
 
Sr
. 
no
. 
Drug Latin 
name 
Par
t 
use
d 
Quantit
y 
1 Amalak
i 
Embelica 
officinalis 
Frui
t 
1 part 
2 Harita
ki 
Terminali
a chebula 
Frui
t 
1 part 
3 Guduc
hi 
Tinospora 
cordifolia 
Ste
m 
1 part 
4 Katuka Piccrorhi
za kurroa 
Roo
t 
1 part 
 
Dose and duration: 
The formulation ‘Amalakyadi Kwatha’ 
was given P.O.(per oral) in the dose of 20 
ml twice a day (morning and evening) for 
the duration of one month. 
 
Assessment criteria: 
Sign and symptoms of all the 
patients were observed before and after the 
treatment. Weight of all the patients was 
also recorded. Along with this the various 
parameters like abdominal girth, distance 
between umbilicus to xiphisternum, 
umbilicus to pubis, umbilicus to right and 
left anterior superior iliac crest was 
measured before and after the treatment. 
 
Investigations: 
In the investigations SGPT and 
SGOT values of all the patients were 
studied.  
 
Statistical analysis: 
Statistical analysis was done by 
applying students paired t test and 
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percentage of improvement was calculated 
by the formula as 
(Total B.T. – Total A.T) × 100 
        Total B. T. 
 
Observations and results: 
Weight of the patients was reduced 
by 12.13% which was statistically highly 
significant. Abdominal girth in sitting 
position was reduced by 7.12% whereas in 
supine position it was reduced by 7.13%. 
Both these parameters showed highly 
significant results. Among the various 
distances measured, distance between 
umbilicus and xiphisternum was reduced 
by 15.60% and 17.34% in sitting and 
supine position respectively. Likewise, the 
distance between umbilicus and pubis by 
19.13% and 19.18%, distance between 
umbilicus and right anterior superior iliac 
crest by 23.73% and 19.55% while the 
distance between umbilicus and left 
anterior superior iliac crest by 15.83% and 
16.83% in sitting and supine position 
respectively. All the parameters showed 
statistically highly significant results. 
SGPT and SGOT were decreased by 
83.30% and 82.64% respectively which 
showed highly significant results. 
 
Discussion: 
The mainstay of treatment for 
hepatic encephalopathy is to use lactulose, 
a non-absorbable disaccharide, which 
results in colonic acidification. The goal of 
lactulose therapy is to promote 2-3 soft 
stools per day.(3) 
According to Harrison, patients of 
small amounts of ascites can usually be 
managed with dietary sodium restriction 
alone. When a moderate amount of ascites 
is present, diuretic therapy is usually 
necessary. If ascites is still present with 
high doses of diuretics in patients who are 
compliant with a low sodium diet, then 
they are defined as having refractory 
ascites, and alternative treatment 
modalities including repeated large 
volume paracentesis, or a TIPS procedure 
should be considered. Recent studies have 
shown that, TIPS while managing he 
ascites, does not improve survival of 
patients. Unfortunately, TIPS is often 
associated with an increased frequency of 
hepatic encephalopathy. The prognosis for 
patients of cirrhosis with ascites is poor 
and some studies have shown that <50% 
of patients survive 2 years after the onset 
of ascites. So, there should be 
consideration for liver transplantation in 
patients with the onset of ascites.(4) Thus, 
to avoid repeated paracentesis and also 
transplantation, it was planned to use the 
Ayurvedic medicine for such disease; also 
it was observed that by taking 
‘Amalakyadi Kwatha’ for this disease, 
patients are surviving for 5-10 years or 
more. Among the ingredients of the 
formulation Amalakyadi Kwatha, Amalaki 
is told as agnideepaka, Tridoshahara and 
Kledashoshaka.(5)  It is also used for 
Virechana. Haritaki is virechaka and it is 
directly indicated in the diseases like 
Kamala (jaundice) and Udara (ascites).(6) 
Guduchi is indicated in the diseases of 
Yakrit and Pleeha.(7) Beside these actions 
mentioned above all these drugs are 
Rasayana and hence they were selected for 
the treatment in ALD. Regarding Katuka it 
is mentioned that it eliminates the waste 
from the gut without getting absorbed.(8) 
Most of the patients gained weight 
which is supportive of the data that people 
with liver disease caused by alcohol abuse 
may also gain weight or appear swollen.(9) 
This develops because the body is 
retaining fluid. Pedal Oedema was also 
observed in almost all the patients which 
was pitting in nature. The edema is a 
consequence of the hypoalbuminemia and 
the kidneys retaining salt and water.(10) In 
patients with chronic diseases of the liver, 
fibrosis (scarring) of the liver often occurs. 
When the scarring becomes advanced, the 
condition is called cirrhosis of the liver. 
Ascites is excessive fluid that accumulates 
in the abdominal (peritoneal) cavity. It is a 
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complication of cirrhosis and appears as an 
abdominal bulge.  
In the present study the mean values 
of SGPT and SGOT were 259.93 and 
296.10 respectively indicating the severe 
liver damage. 
During the period of whole study no 
any adverse drug reactions noted. 
 
Probable mode of action: 
Amalaki: 
Ascorbic acid present in Amalaki 
prevents hepato toxicity. The fruits are 
reported to activate trypsin activity and 
found to be effective in acute viral 
hepatitis.(11) 
Haritaki: 
The fruits showed hepato 
protective activity against CCl4 and 
paracetamol liver injury in rats.  
The dried flesh surrounding the 
seed is rich in tannins that showed 
antioxidant and protective effect on liver 
damage. Oral administration of tannin 
isolated from T. chebula antagonized the 
increase in SGPT, induced by aminopyrin 
and NaNO3 in mice. (12) 
 
Guduchi: 
The plant extract is used as 
immunomodulator in immune suppression 
of obstructive jaundice and hepatic 
fibrosis. It was found effective in 
preventing fibrous changes in liver and 
promoting regeneration of liver in CCl4 
induced hepato toxicity. A decoction of 
Guduchi initially aggravates acute damage 
to the liver but then is able to prevent 
fibrotic changes and enhance liver tissue 
regeneration. (13) 
Treatment with Guduchi reduced 
levels of bilirubin and alkaline 
phosphatase. The palnt extract showed in 
vitro inactivating activity in hepatitis B 
surface antigen in 48-72 hrs.(14) 
 
Katuka: 
P. kurroa is mainly used as a cure 
for liver diseases. The drug exhibited 
definite action in the process of clearance 
of hepatitis much faster than its placebo 
control. 
It is also reported to exhibit potent 
immuno modulatory activity and is 
considered as immunomodulatory agent. 
Kutkin, a mixture of iridoid glycosides 
isolated from this plant has been reported 
to show hepato protective properties in 
CCl4 induced toxic rats. (15) 
Picroliv, a standardized fraction 
from the alcoholic extract of root and 
rhizome of this plant showed significant 
protection against hepatic damage and 
found to be more potent than silymarin, a 
known hepatoprotective agent. (16) 
 
Conclusion: 
The disease ALD can be compared 
with Sannipataj Udara according to 
Ayurveda on the basis of similarity 
between causes and symptoms. 
The formulation Amalakyadi Kwatha 
was found an excellent remedy for the 
alcoholic liver disease. It showed 
significant results on weight gain, pedal 
edema and abdominal enlargement. The 
formulation also significantly reduced the 
levels of SGPT and SGOT.
 
 
Table 1: Effect of Amalakyadi kwatha on weight of the patients of ALD  
Parameter Mean score Mean 
diff. 
%  
change 
SD SEM t P 
(n=30) BT AT 
Weight 63.20 55.53 7.66 12.13↓ 7.66 0.99 7.68 P<0.001 
 
n: number of patients; BT: before treatment; AT: after treatment; ↓: decrease; 
SD: standard deviation; SEM: standard error; P<0.001: highly significant 
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Table 2: Effect of Amalakyadi Kwatha on various parameters of ALD in sitting position 
Parameter Mean score Mean 
diff. 
%  
change 
SD SEM t P 
(n=30) BT AT 
Abdominal 
Girth 
88.93 82.60 6.33 7.12↓ 2.72 0.50 12.75 P<0.001 
Dist. bet. 
Umbilicus - 
xiphisternum 
19.86 16.76 3.10 15.60↓ 1.63 0.30 10.44 P<0.001 
Dist. bet. 
Umbilicus – 
pubis 
16.90 13.67 3.23 19.13↓ 1.91 0.35 9.29 P<0.001 
Dist. bet. 
Umbilicus – 
RAS iliac 
crest 
25.00 19.07 5.93 23.73↓ 4.94 0.90 6.57 P<0.001 
Dist. bet. 
Umbilicus – 
LAS iliac 
crest 
24.00 20.20 3.80 15.83↓ 3.44 0.63 6.05 P<0.001 
 
 
Table 3: Effect of Amalakyadi Kwatha on various parameters of ALD in supine position 
Parameter Mean score Mean 
diff. 
%  
change 
SD SEM t P 
(n=30) BT AT 
Abdominal 
Girth 
80.47 74.73 5.73 7.13↓ 4.48 0.82 7.01 P<0.001 
Dist. bet. 
Umbilicus - 
xiphisternum 
21.53 17.80 3.73 17.34↓ 1.46 0.27 14.00 P<0.001 
Dist. bet. 
Umbilicus – 
pubis 
21.20 17.13 4.07 19.18↓ 1.80 0.33 12.38 P<0.001 
Dist. bet. 
Umbilicus – 
RAS iliac 
crest 
20.80 16.73 4.07 19.55↓ 2.27 0.42 9.80 P<0.001 
Dist. bet. 
Umbilicus – 
LAS iliac 
crest 
21.00 17.47 3.53 16.83↓ 2.25 0.41 8.58 P<0.001 
 
Table 4: Effect of Amalakyadi Kwatha on SGPT and SGOT values of ALD patients 
Parameter Mean score Mean 
diff. 
%  
change 
SD SEM t P 
(n=30) BT AT 
SGPT 259.93 43.4 216.53 83.30↓ 157.69 28.79 7.52 P<0.001 
SGOT 296.10 51.40 244.70 82.64↓ 137.54 25.11 9.75 P<0.001 
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Chart 1: Effect of Amlakyadi Kwatha on various parameters of ALD in sitting position 
 
 
Chart 2: Effect of Amlakyadi Kwatha on various parameters of ALD in supine position 
 
 
 
Chart 3: Effect of Amalakyadi Kwatha on SGPT and SGOT values of ALD patients 
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